Condition: Preeclampsia · Sponsor: Lina Bergman
Preterm preeclampsia is a severe condition for both the mother and the fetus. Currently, the only treatment available to stop disease progression is termination/delivery of the fetus and placenta. Therefore, preterm preeclampsia carries the highest rates of neonatal morbidity and mortality due to iatrogenic preterm birth. There is evidence suggesting metformin, a drug commonly used to treat diabetes in and outside pregnancy, may be able to counter the pathophysiology of preeclampsia, raising the possibility that it could be used to treat the condition. This multi centre double blind randomised controlled trial aims to investigate if metformin can prolong gestation, lower neonatal length of stay and increase birthweight in a Nordic setting.
This description comes directly from the study's public registry record.
Lina Bergman, Associate Professor · 0046-3134307 · lina.bergman@obgyn.gu.se
Pia Gudmundsson, PhD · 0046-313434327 · pia.gudmundsson@obgyn.gu.se
Always discuss trial participation with your own doctor first.
| Helsinki University Hospital | Helsinki, Finland | Not Yet Recruiting |
| Tampere University Hospital | Tampere, Finland | Recruiting |
| Akershus University Hospital | Lørenskog, Norway | Not Yet Recruiting |
| Oslo University Hospital | Oslo, Norway | Recruiting |
| Södra Älvsborgs Hospital | Borås, Sweden | Recruiting |
| Falu Lasarett | Falun, Sweden | Recruiting |
| Sahlgrenska University Hospital | Gothenburg, Sweden | Recruiting |
| Linköping University Hospital | Linköping, Sweden | Recruiting |
| Skåne University Hospital | Lund, Sweden | Recruiting |
| Skåne University Hospital | Malmö, Sweden | Recruiting |
| Karolinska University Hospital Huddinge | Stockholm, Sweden | Recruiting |
| Karolinska University Hospital Solna | Stockholm, Sweden | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06033131